Elizabeth Fox Selected Research

O(4)-benzylfolic acid

6/2011

Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth Fox Research Topics

Disease

80	Neoplasms (Cancer) 03/2024 - 10/2005
18	Neuroblastoma 01/2023 - 01/2010
7	Osteosarcoma (Osteogenic Sarcoma) 03/2024 - 01/2010
7	Ewing Sarcoma (Sarcoma, Ewing) 12/2022 - 01/2010
6	Lymphoma (Lymphomas) 11/2023 - 01/2008
6	Plexiform Neurofibroma 10/2022 - 01/2006
6	Nausea 12/2020 - 01/2008
5	Central Nervous System Neoplasms 01/2024 - 01/2018
5	Brain Neoplasms (Brain Tumor) 11/2023 - 01/2004
5	Rhabdomyosarcoma 01/2023 - 01/2010
5	Glioma (Gliomas) 01/2023 - 10/2017
5	Vomiting 12/2020 - 01/2008
5	Fatigue 01/2018 - 02/2008
5	Neurofibromatosis 1 (Neurofibromatosis Type I) 09/2014 - 01/2006
4	Disease Progression 11/2023 - 12/2017
4	Leukemia 01/2019 - 01/2008
4	Thyroid Neoplasms (Thyroid Cancer) 01/2018 - 02/2012
3	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 12/2009
3	Thrombocytopenia (Thrombopenia) 11/2021 - 11/2012
3	Wilms Tumor (Wilm's Tumor) 12/2020 - 01/2010
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2020 - 01/2017
3	Hypertension (High Blood Pressure) 12/2018 - 11/2012
3	Mucositis 01/2018 - 11/2012
3	Diarrhea 01/2018 - 11/2012
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 01/2022
2	Febrile Neutropenia 01/2022 - 12/2009
2	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2020
2	Diffuse Intrinsic Pontine Glioma 01/2022 - 01/2022
2	Fever (Fevers) 01/2022 - 12/2009
2	Exanthema (Rash) 01/2022 - 11/2012
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2012
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2018
2	Proteinuria 01/2021 - 01/2018
2	Neurofibrosarcoma (MPNST) 12/2020 - 01/2010
2	Synovial Sarcoma (Synovioma) 12/2020 - 01/2010
2	Hyperglycemia 12/2020 - 01/2008
2	Dehydration (Water Stress) 01/2020 - 11/2012
2	Abdominal Pain (Pain, Abdominal) 08/2018 - 01/2008
2	Hypothyroidism 01/2018 - 01/2015
2	Neutropenia 01/2018 - 12/2009
2	Autistic Disorder (Autism) 01/2016 - 10/2012
2	Multiple Endocrine Neoplasia Type 2b (MEN 3) 01/2015 - 08/2013
2	Headache (Headaches) 12/2010 - 01/2008

Drug/Important Bio-Agent (IBA)

7	Phosphotransferases (Kinase)IBA 01/2023 - 04/2012
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 05/2014
6	MLN 8237IBA 01/2022 - 09/2010
6	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 04/2012
6	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 10/2005
5	CrizotinibIBA 11/2021 - 01/2017
5	ABT751IBA 06/2014 - 08/2006
4	Tyrosine Kinase InhibitorsIBA 10/2022 - 12/2018
4	Alanine Transaminase (SGPT)IBA 12/2020 - 11/2012
3	adavosertibIBA 01/2023 - 01/2020
3	entrectinibIBA 01/2023 - 10/2022
3	Mitogen-Activated Protein KinasesIBA 12/2022 - 10/2017
3	Lipase (Acid Lipase)FDA Link 11/2021 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 04/2010
3	Transaminases (Aminotransferases)IBA 01/2018 - 01/2008
3	vandetanib (ZD6474)IBA 01/2018 - 08/2013
3	tipifarnib (R115777)IBA 05/2014 - 01/2006
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 01/2014
2	cabozantinibIBA 01/2023 - 01/2018
2	larotrectinibIBA 01/2023 - 01/2021
2	trametinibIBA 01/2023 - 01/2023
2	NivolumabIBA 12/2022 - 01/2020
2	dipinacoline glutamateIBA 01/2022 - 01/2022
2	Anaplastic Lymphoma KinaseIBA 11/2021 - 01/2021
2	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2017
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2014
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 01/2020
2	tyrosine receptor (receptor, tyrosine)IBA 01/2021 - 12/2018
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2020 - 11/2012
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2016
2	Monoclonal AntibodiesIBA 01/2020 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2018
2	TrabectedinIBA 10/2019 - 11/2012
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2018 - 12/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 12/2015
2	thiamine triphosphorate (TTP)IBA 12/2017 - 06/2014
2	dinutuximabIBA 12/2017 - 11/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2011
2	Alkaline PhosphataseIBA 01/2017 - 11/2012
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2017 - 11/2012
2	Aurora Kinase AIBA 04/2016 - 11/2012
2	AutoantibodiesIBA 01/2016 - 10/2012
2	Docetaxel (Taxotere)FDA Link 12/2015 - 01/2012
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2015 - 04/2007
2	tariquidar (XR9576)IBA 12/2015 - 04/2007
2	pirfenidoneIBA 09/2014 - 05/2007
2	MTOR InhibitorsIBA 05/2014 - 06/2010
2	Farnesyltranstransferase (Farnesyltransferase)IBA 05/2014 - 01/2006
2	Gemcitabine FDA Link 01/2012 - 07/2008
2	ixabepilone (BMS 247550)FDA Link 01/2010 - 02/2009

Therapy/Procedure

24	Therapeutics 12/2023 - 01/2004
10	Drug Therapy (Chemotherapy) 11/2023 - 04/2007
2	Duration of Therapy 12/2022 - 10/2022
2	Immunotherapy 01/2022 - 01/2018
2	Intravenous Infusions 10/2019 - 11/2012